Search results
Lyophilized platelets
Measurement of ristocetin cofactor activity of vWF.
BIOPHEN Factor VIII:C 6
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A). Follow-up of FVIII recovery in treated patients. Measurement of high FVIII concentrations.
BIOPHEN Factor VIII:C 2.5
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A). Follow-up of FVIII recovery in treated patients. Measurement of high FVIII concentrations.
BIOPHEN DTI (Direct Thrombin Inhibitors)
Assay proposed for the measurement of anti-IIa activity in research applications.
Tris buffer - progressive AT - Anti Xa, pH 7.85
Dilution buffer for progressive antithrombin activity assay, using a variant protocol for BIOPHEN®Antithrombin kit (ref. 221102/221105).
Tris buffer - progressive AT - Anti IIa, pH 8.40
Dilution buffer for progressive antithrombin activity using an anti IIa method, and a variant protocol of BIOPHEN®AT (Anti IIa) kit (ref. 221122), performed in the absence of heparin.
BIOPHEN Heparin anti-IIa (Kinetics)
Assay proposed for the measurement of heparin in research applications.
BIOPHEN Heparin (AT+)
Assay proposed for the measurement of heparin in research applications.
BIOPHEN Heparin 6
Measuring the heparin concentration in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin 3
Measuring the heparin concentration in patients’ plasma for monitoring the therapy and adjusting drug dosage.